Kahn Brothers Kahn Brothers Group
Kahn Brothers Group is a value investment firm founded in the tradition of Benjamin Graham and long associated with the Kahn family of investors. The firm is known for deep-value security analysis, patience, and a multi-decade orientation to intrinsic value. Its filings are followed by classic value investors seeking Graham-and-Dodd style managers still active in public markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Organon & Co
OGN
|
+$19.6M |
| 2 |
BAY
BAYER AG SPONS ADR
BAY
|
+$18.3M |
| 3 |
Walt Disney
DIS
|
+$9.81M |
| 4 |
MBIA
MBI
|
+$2.2M |
| 5 |
FFH
FAIRFAX FINL HLDGS LTD SUB VTG
FFH
|
+$1.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Patterson-UTI
PTEN
|
+$9.42M |
| 2 |
BlackBerry
BB
|
+$4.45M |
| 3 |
BP
BP
|
+$1.73M |
| 4 |
Haleon
HLN
|
+$1.43M |
| 5 |
Assured Guaranty
AGO
|
+$1.41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.93% |
| 2 | Financials | 33.19% |
| 3 | Energy | 14.46% |
| 4 | Consumer Staples | 4.45% |
| 5 | Communication Services | 3.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Assured Guaranty
AGO
$3.27B
| $84.7M | 12.56% |
970,580
-16,792
| -2% | -$1.41M |
|
2
Merck
MRK
$376B
| $81M | 12.01% |
613,815
-10,726
| -2% | -$1.32M |
|
3
Citigroup
C
$221B
| $75.9M | 11.25% |
1,199,446
-9,922
| -0.8% | -$552K |
|
|
4
BP
BP
$115B
| $62.8M | 9.31% |
1,665,620
-48,234
| -3% | -$1.73M |
|
5
GSK
GSK
$105B
| $53.7M | 7.97% |
1,253,644
-5,838
| -0.5% | -$241K |
|
6
Bristol-Myers Squibb
BMY
$137B
| $45.1M | 6.69% |
831,991
-1,925
| -0.2% | -$98.1K |
|
|
7
MBIA
MBI
$250M
| $35M | 5.19% |
5,176,613
+347,007
| +7% | +$2.2M |
|
|
8
Patterson-UTI
PTEN
$4.71B
| $31.7M | 4.7% |
2,652,332
-847,666
| -24% | -$9.42M |
|
9
Seaboard Corp
SEB
$4.08B
| $29.2M | 4.33% |
9,052
+89
| +1% | +$306K |
|
10
Pfizer
PFE
$160B
| $28.4M | 4.21% |
1,022,719
-2,962
| -0.3% | -$82.2K |
|
|
BAY
11
DELISTED
BAYER AG SPONS ADR
BAY
| $23.7M | 3.52% |
3,099,140
+2,386,640
| +335% | +$18.3M |
|
|
VOXX
12
DELISTED
VOXX International Corporation Class A
VOXX
| $23.3M | 3.45% |
2,849,526
-28,038
| -1% | -$241K |
|
|
13
Organon & Co
OGN
$3.61B
| $22.2M | 3.29% |
1,180,204
+1,144,894
| +3,242% | +$19.6M |
|
|
FLG
14
Flagstar Bank National Association
FLG
$5.59B
| $20M | 2.97% |
2,071,096
+17,758
| +0.9% | +$328K |
|
15
IDT Corp
IDT
$1.69B
| $13.1M | 1.94% |
345,548
-1,544
| -0.4% | -$55.2K |
|
|
16
Walt Disney
DIS
$186B
| $11.5M | 1.7% |
+93,932
| New | +$9.81M |
|
|
WBS
17
DELISTED
Webster Financial
WBS
| $4.97M | 0.74% |
97,935
-3,138
| -3% | -$153K |
|
18
Genie Energy
GNE
$395M
| $4.43M | 0.66% |
293,690
-2,150
| -0.7% | -$41.3K |
|
|
19
Haleon
HLN
$44B
| $4.03M | 0.6% |
474,281
-171,394
| -27% | -$1.43M |
|
|
HOLX
20
DELISTED
Hologic
HOLX
| $2.06M | 0.31% |
26,491
-2,000
| -7% | -$149K |
|
21
CSX Corp
CSX
$95.6B
| $1.86M | 0.28% |
50,320
| – | – |
|
22
ExxonMobil
XOM
$679B
| $1.65M | 0.24% |
14,167
-1,056
| -7% | -$110K |
|
23
Novartis
NVS
$302B
| $1.49M | 0.22% |
15,413
-2,650
| -15% | -$272K |
|
24
Bank of America
BAC
$431B
| $1.29M | 0.19% |
33,901
-7,084
| -17% | -$243K |
|
|
FFH
25
DELISTED
FAIRFAX FINL HLDGS LTD SUB VTG
FFH
| $1.1M | 0.16% |
+1,018
| New | +$1.1M |
|
Similar funds
Kahn Brothers's Q1 2024 Portfolio in Review
As of Q1 2024, Kahn Brothers held 56 positions worth $674M, up 6.2% from $635M the previous quarter. Its ten largest holdings account for 78% of the portfolio.
Kahn Brothers deployed $32.1M of net new capital in Q1 2024, opening 13 new positions and adding to 6 existing holdings. Its largest new stake was Walt Disney: 93,932 shares worth $11.5M.
By sector, the portfolio is most concentrated in Healthcare at 39% of assets, up from 32% a quarter earlier, followed by Financials and Energy.
On the sell side, the largest reduction was Patterson-UTI, an estimated $9.42M trimmed.
- Kahn Brothers's largest Q1 2024 buy was Walt Disney: 93,932 shares worth $11.5M.
- Kahn Brothers added most to Organon & Co in Q1 2024, an estimated $19.6M increase.
- Kahn Brothers's biggest Q1 2024 reduction was Patterson-UTI, cutting an estimated $9.42M.
- Kahn Brothers fully exited BlackBerry in Q1 2024, selling an estimated $4.45M.
- Kahn Brothers's ten largest holdings make up 78% of its $674M portfolio in Q1 2024.
- Kahn Brothers opened 13 new positions and closed 3 in Q1 2024.
- Kahn Brothers's portfolio value rose 6.2% quarter-over-quarter to $674M.
Based on Kahn Brothers Group's 13F filing for Q1 2024, filed 15 May 2024.